Our latest paper on #Cancers! ➡️ Retrospective single-center study 👥 109 pts undergoing MIS for CRC (lap VS rob with HugoRAS) 📊 No differences in terms of short-term oncologic outcomes 📨 Rob surgery with HugoRAS is as safe and feasible as laparoscopy for CRC.

Thrilled to see that our recent publication from the CASCADE study has been in the top 5 most read BJS articles since its publication back in March!

Hot off the press 2025 Delphi consensus on #robotic ventral mesh #rectopexy #openaccess here: https://t.co/1CwUOCYLsi

Thanks to the COVID-CRC Collaborative Group 🇮🇹and to the authors @ MatteoRottoli @Carste92 @alice_gori @ClaudioIsopi @DFerrariMD @DrEmanueleRausa @GianlucaPellino @AntoninoSpin and all the authors

🚨🚨🚨 New study alert "Rectal cancer surgery TIMING after neoadjuvant therapy: balancing downstaging and perioperative outcomes" just published in Surgical Oncology https://t.co/uBlKzgxJqC

👏 𝗔 𝗵𝘂𝗴𝗲 𝗱𝗮𝘆 𝗼𝗳 𝗹𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗮𝘁 𝘁𝗵𝗲 #𝗘𝗦𝗖𝗣𝟮𝟱 𝗣𝗿𝗲-𝗖𝗼𝗻 𝗖𝗼𝘂𝗿𝘀𝗲𝘀! Delegates got hands-on with: 🧷 How to Manage OASIS 🧠 EBSQ Prep  📊 Systematic Review for Guideline Development 🌟 Talent Masterclass 💥 Anal Fistula & Haemorrhoid Hands-on

Higher mortality rates among surgeons vs non-surgeon physicians may reflect differences related to work environment, professional demands, and lifestyle. https://t.co/zTaN01v0bw @AnupamBJena

Most viewed this week from @JAMASurgery: Preoperatively started antibiotic treatment did not decrease the risk of appendiceal perforation rate in acute uncomplicated appendicitis. https://t.co/B7vJFYofO6

New Meta-Analysis on Neoadjuvant Chemotherapy in Colon Cancer from Mayo Clinic - Christopher Williams @RichardSassun | @DrDavidLarson | @EricDozoisMD | @3isac https://t.co/tBCIceZPme #Cancer #ColonCancer #MayoClinic #MedEd #MedX #NeoadjuvantChemotherapy #OncoDaily #Oncology

Diverticulitis' incidence is rising, but surgery is not always recommended, especially for uncomplicated cases. We delved into the relationship of surgery, quality of life, and cytokine levels, revealing a benefit with surgery. Read the full paper here!🔥 https://t.co/LP6EZNYkNr

🚨 Exercise is no longer optional, it is essential! One of the most impactful studies at #ASCO25 🏃‍♂️ The #CHALLENGE trial (LBA4319) proves that structured exercise after chemo in stage III colon cancer is not just lifestyle—it’s life-saving. 📊 5y DFS: 80.3% vs 73.9% ❤️ 8y OS:

🚨 New data on #temporarystomas in #Crohnsdisease: 🔹 Reversal @ 6mo: 30.2% 🔹 Reversal @ 18mo: 56.9% 🔹 Non-reversal: med therapy (39%), unfit (17%), patient's choice (20%) 🔹 Stoma morbidity: 29.4% "Temporary" often isn’t. #IBDsurgery @BjsOpen @GCalini @ZGaroufalia @SWexner

@GCalini @escp_tweets @SIC_chirurgia @colothrive @YouSICCR @MedtronicITA @Medtronic @FightCRC @ECCongress

Full text here:

Delayed Gastric Emptying 🤢 is an issue after robotic 🤖 PD 2️⃣1️⃣ % overall DGE rate 📹 assessment of technical skills ⬇️ DGE rates (after 35 procedures) 🤔 How do you perform GJ after a robotic PD ?! How do you prevent DGE?! 🫵 https://t.co/un1Zdgr2eC

Augmented reality (AR) enhances surgical procedures by overlaying patient-specific anatomy onto the surgeon's view, improving visualization, decision-making, and potentially reducing operative times and complications. https://t.co/fD4fFc6tde

Ready for #Day2 of #SurgicalAI& #TelesurgeryDays @orsiacademy

Mirizzi syndrome Type V: a true nightmare

🚨RECOMMENDED READ🚨 All you need to know about primary ventral and incisional hernias, including detailed open and mini invasive surgical approaches and great illustrations!! ➡️ https://t.co/BHxaMs0H9I Dont miss this great comprehensive review by @DrHenriksen, @HeatherBougard,

Routine imaging after pancreatic ductal adenocarcinoma (PDAC) resection was associated with increased recurrence-focused treatment and improved survival in this multicenter study.